Yih-Huei Uen

Title: Yih-Huei Uen: Innovator in Liver Cancer Biomarkers

Introduction

Yih-Huei Uen is a notable inventor based in Tainan, Taiwan. He has made significant contributions to the field of medical research, particularly in the area of cancer detection. His innovative work focuses on developing methods to identify liver cancer in patients, which can lead to earlier diagnosis and treatment.

Latest Patents

Yih-Huei Uen holds a patent for a groundbreaking biomarker for human liver cancer. The patent describes a method for determining the incidence of liver cancer in a subject by detecting the methylation level or expression level of the microRNA miR-129-2 in a bio-sample. If the methylation level of the microRNA in the bio-sample is higher, or the expression level is lower compared to a control sample, it indicates that the subject may be predisposed to or afflicted with liver cancer. This innovative approach has the potential to improve early detection and patient outcomes.

Career Highlights

Uen is affiliated with the Industrial Technology Research Institute, where he continues to advance his research and development efforts. His work is characterized by a commitment to enhancing medical diagnostics and improving healthcare solutions.

Collaborations

Yih-Huei Uen collaborates with esteemed colleagues, including Cheng-Tao Wu and Kai-Yuan Lin. These partnerships foster a collaborative environment that enhances the quality and impact of their research.

Conclusion

Yih-Huei Uen's contributions to the field of liver cancer detection through innovative biomarker research exemplify the importance of scientific advancement in healthcare. His work not only highlights his expertise but also underscores the potential for innovation to transform medical diagnostics.